logo

Biodelivery Sciences International Inc (BDSI)



Trade BDSI now with
  Date
  Headline
5/11/2020 8:39:42 AM BioDelivery Sciences Names Jeff Bailey Interim CEO
1/13/2020 8:38:31 AM BDSI Expects 2019 Total Company Net Sales At Upper End Of $105 Mln-$110 Mln
11/25/2019 8:42:05 AM BioDelivery Sciences Names Vanila Singh To Its Board
4/11/2019 9:37:21 AM BDSI Reports Pricing Of Public Offering By Company, Selling Stockholder
1/15/2019 8:09:21 AM ArunA Bio Appoints Mark Sirgo As CEO
1/15/2019 7:33:40 AM BioDelivery Sciences Intl. Names Terry Coelho CFO
12/13/2018 7:02:58 AM Antares Pharma Appoints Peter Greenleaf To Board Of Directors
12/11/2018 8:33:33 AM Avadel Pharma Appoints Kevin Kotler To Board
10/29/2018 8:35:35 AM BioDelivery Sciences CFO Ernest De Paolantonio Plan To Retire By Mid-2019
8/15/2018 9:27:24 AM BioDelivery Sciences Secures Significant Expanded Preferred Coverage For BELBUCA
7/30/2018 7:57:11 AM BioDelivery Sciences Appoints Thomas Smith As Chief Medical Officer And Member Of Executive Leadership Team
5/22/2018 8:29:52 AM BioDelivery Sciences Closes $50 Mln Registered Direct Offering
5/17/2018 8:10:01 AM BioDelivery Sciences Announces Pricing Of $50 Mln Equity Financing
5/7/2018 9:07:39 AM BioDelivery Sciences Names Herm Cukier CEO And A Member Of Board
5/3/2018 9:07:05 AM BioDelivery Sciences Confirms Receipt Of Notice Of Intent To Nominate Directors By Broadfin Capital
2/6/2018 7:11:41 AM BioDelivery Sciences Announces BELBUCA Patent Litigation Settlement Agreement With Teva